Jeffry Keyes Sells 8,627 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CFO Jeffry Keyes sold 8,627 shares of Quantum-Si stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $11,042.56. Following the completion of the sale, the chief financial officer owned 1,163,197 shares in the company, valued at approximately $1,488,892.16. This trade represents a 0.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Quantum-Si Stock Down 3.1%

QSI opened at $1.23 on Wednesday. The company has a market cap of $265.05 million, a PE ratio of -1.84 and a beta of 2.96. Quantum-Si Incorporated has a twelve month low of $0.95 and a twelve month high of $5.77. The company has a 50-day moving average price of $1.64 and a 200 day moving average price of $1.58.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.17). Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%.The company had revenue of $0.55 million for the quarter, compared to analysts’ expectations of $0.60 million. As a group, sell-side analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current year.

Institutional Trading of Quantum-Si

Hedge funds and other institutional investors have recently modified their holdings of the stock. Prudential Financial Inc. purchased a new position in shares of Quantum-Si during the 2nd quarter worth $25,000. JTC Employer Solutions Trustee Ltd acquired a new stake in Quantum-Si during the second quarter worth about $26,000. Capital Investment Advisory Services LLC raised its stake in Quantum-Si by 100.0% during the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after purchasing an additional 10,000 shares during the period. Elite Life Management LLC purchased a new position in Quantum-Si during the third quarter worth about $29,000. Finally, Cerity Partners LLC acquired a new position in Quantum-Si in the 2nd quarter valued at about $29,000. 39.90% of the stock is owned by institutional investors and hedge funds.

Quantum-Si News Roundup

Here are the key news stories impacting Quantum-Si this week:

• Positive Sentiment: Launched Version 3 library‑preparation kit and a suite of data‑analysis enhancements — a commercial update that could help drive consumable kit revenue, customer adoption and evidence of execution. Read More.
• Neutral Sentiment: Canaccord cut its price target from $2.00 to $1.50 and set a “hold” — this reduces near‑term analyst support (the new PT still implies modest upside from some current levels) and is a near‑term sentiment headwind. Read More.
• Negative Sentiment: CEO Jeffrey Hawkins sold 23,707 shares at ~$1.28 (~$30.3k), trimming his stake by ~0.91% — meaningful because CEO selling can signal reduced near‑term insider conviction. Read More.
• Negative Sentiment: CFO Jeffry R. Keyes sold 8,627 shares at ~$1.28 (~$11.0k), a ~0.74% reduction — adds to the selling signal given other insiders also sold the same day. Read More.
• Negative Sentiment: Director John S. Vieceli sold 21,927 shares at ~$1.28 (~$28.1k), trimming his holding by ~2.66% — multiple insiders selling in one session amplifies investor concern about near‑term insider conviction. Read More.

Wall Street Analyst Weigh In

QSI has been the topic of a number of research reports. Canaccord Genuity Group decreased their price objective on Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a report on Monday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research report on Monday. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Quantum-Si presently has a consensus rating of “Hold” and a consensus price target of $3.60.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.